M1A.452 Other secondary chronic gout, left hip

Name of the Condition

• Other Secondary Chronic Gout, Left Hip

Summary

Other secondary chronic gout, left hip is a form of arthritis affecting the left hip joint, resulting from elevated uric acid levels due to an identifiable underlying condition or cause. It leads to recurrent joint inflammation and potential tissue damage, with symptoms that may persist over time. Advanced stages can involve the formation of tophi (urate crystal deposits) in the hip area.

Causes

Other secondary chronic gout, left hip arises from an underlying condition that disrupts uric acid metabolism, causing accumulation in the blood. This can stem from overproduction of uric acid or reduced renal clearance due to factors like chronic kidney disease, certain medications, or hematologic disorders. Over time, urate crystals deposit in the left hip joint and surrounding tissues, triggering inflammation.

Risk Factors

• Underlying conditions that affect uric acid metabolism (e.g., certain hematologic disorders, enzyme deficiencies)
• Medications that increase uric acid levels (e.g., some diuretics, chemotherapy agents)
• Chronic kidney disease or renal impairment
• History of gout or hyperuricemia
• Exposure to substances that disrupt uric acid excretion

Symptoms

• Recurrent episodes of intense hip pain, often with swelling and redness
• Persistent warmth and tenderness in the hip joint
• Stiffness and limited range of motion in the left hip
• Possible formation of tophi (visible lumps) in the hip area over time

Diagnosis

Diagnosis involves a combination of clinical evaluation, patient history, and laboratory tests. Joint fluid analysis may confirm the presence of urate crystals. Imaging studies like X-rays or ultrasound can assess joint damage or tophi. Blood tests to measure uric acid levels and evaluate kidney function are also typically performed. The underlying cause of secondary gout is identified through additional testing as needed.

Treatment Options

Treatment focuses on managing symptoms, reducing uric acid levels, and addressing the underlying condition. Medications may include nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, or corticosteroids for acute flares. Long-term management often involves urate-lowering therapy (e.g., allopurinol, febuxostat) and lifestyle modifications. Physical therapy may help maintain joint function.

Prognosis and Follow-Up

With proper management, symptoms can be controlled, and joint damage may be minimized. Regular follow-up is important to monitor uric acid levels, adjust medications, and address complications. Untreated or poorly managed cases may lead to progressive joint damage and disability.

Complications

• Chronic joint damage or deformity in the left hip
• Formation of tophi, which can cause pain or functional impairment
• Kidney stones or renal impairment due to uric acid accumulation
• Increased risk of infections in affected joints

Lifestyle & Prevention

• Maintain a healthy weight to reduce joint stress
• Limit intake of purine-rich foods (e.g., red meat, seafood) and alcohol
• Stay hydrated to support kidney function
• Follow prescribed medication regimens consistently
• Avoid medications that may elevate uric acid levels unless necessary

When to Seek Professional Help

Seek medical attention if you experience severe or persistent hip pain, swelling, or stiffness, especially if accompanied by fever or difficulty moving. Prompt evaluation is important for acute flares or signs of infection. Regular check-ups are recommended for ongoing management.

Tips for Medical Coders

Document the specific location (left hip) and confirm the underlying cause of secondary gout when available. Ensure clinical documentation supports the diagnosis and any associated complications. Code M1A.452 is specific to the left hip; verify laterality and exclude cases with tophi if not present.